Correction to: Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) (Cancers, (2024), 16, 5, (998), 10.3390/cancers16050998)

Julia Chisholm; Henry Mandeville; Madeleine Adams; Veronique Minard-Collin; Timothy Rogers; Anna Kelsey; Janet Shipley; Rick R. van Rijn; Isabelle de Vries; Roelof van Ewijk; Bart de Keizer; Susanne A. Gatz; Michela Casanova; Lisa Lyngsie Hjalgrim; Charlotte Firth; Keith Wheatley; Pamela Kearns; Wenyu Liu; Amanda Kirkham; Helen Rees; Gianni Bisogno; Ajla Wasti; Sara Wakeling; Delphine Heenen; Deborah A. Tweddle; Johannes H.M. Merks; Meriel Jenney

doi:10.3390/cancers16193427

Correction to: Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) (Cancers, (2024), 16, 5, (998), 10.3390/cancers16050998)

Julia Chisholm^*, Henry Mandeville, Madeleine Adams, Veronique Minard-Collin, Timothy Rogers, Anna Kelsey, Janet Shipley, Rick R. van Rijn, Isabelle de Vries, Roelof van Ewijk, Bart de Keizer, Susanne A. Gatz, Michela Casanova, Lisa Lyngsie Hjalgrim, Charlotte Firth, Keith Wheatley, Pamela Kearns, Wenyu Liu, Amanda Kirkham, Helen ReesGianni Bisogno, Ajla Wasti, Sara Wakeling, Delphine Heenen, Deborah A. Tweddle, Johannes H.M. Merks, Meriel Jenney

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Abstract

The authors wish to make corrections to the authorship and title of [1]. The corrected authorship is as follows: Julia Chisholm and Henry Mandeville contributed equally to the first authorship. Johannes H. M. Merks and Meriel Jenney contributed equally to senior authorship. In the title FAR-RMS has been corrected to FaR-RMS. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Original language	English
Article number	3427
Journal	Cancers
Volume	16
Issue number	19
DOIs	https://doi.org/10.3390/cancers16193427
Publication status	Published - Oct 2024
Externally published	Yes

Access to Document

10.3390/cancers16193427Licence: CC BY

Fingerprint

Dive into the research topics of 'Correction to: Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) (Cancers, (2024), 16, 5, (998), 10.3390/cancers16050998)'. Together they form a unique fingerprint.

1 Article

Frontline and Relapsed Rhabdomyosarcoma (FAR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)
Chisholm, J., Mandeville, H., Adams, M., Minard-Collin, V., Rogers, T., Kelsey, A., Shipley, J., van Rijn, R. R., de Vries, I., van Ewijk, R., de Keizer, B., Gatz, S. A., Casanova, M., Hjalgrim, L. L., Firth, C., Wheatley, K., Kearns, P., Liu, W., Kirkham, A. & Rees, H. & 7 others, Bisogno, G., Wasti, A., Wakeling, S., Heenen, D., Tweddle, D. A., Merks, J. H. M. & Jenney, M., Mar 2024, In: Cancers. 16, 5, 998.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

Cite this

Chisholm, J., Mandeville, H., Adams, M., Minard-Collin, V., Rogers, T., Kelsey, A., Shipley, J., van Rijn, R. R., de Vries, I., van Ewijk, R., de Keizer, B., Gatz, S. A., Casanova, M., Hjalgrim, L. L., Firth, C., Wheatley, K., Kearns, P., Liu, W., Kirkham, A., ... Jenney, M. (2024). Correction to: Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) (Cancers, (2024), 16, 5, (998), 10.3390/cancers16050998). Cancers, 16(19), Article 3427. https://doi.org/10.3390/cancers16193427

@article{d5ea421f5dbf4e03a84f551e03da761b,

title = "Correction to: Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) (Cancers, (2024), 16, 5, (998), 10.3390/cancers16050998)",

abstract = "The authors wish to make corrections to the authorship and title of [1]. The corrected authorship is as follows: Julia Chisholm and Henry Mandeville contributed equally to the first authorship. Johannes H. M. Merks and Meriel Jenney contributed equally to senior authorship. In the title FAR-RMS has been corrected to FaR-RMS. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.",

author = "Julia Chisholm and Henry Mandeville and Madeleine Adams and Veronique Minard-Collin and Timothy Rogers and Anna Kelsey and Janet Shipley and {van Rijn}, {Rick R.} and {de Vries}, Isabelle and {van Ewijk}, Roelof and {de Keizer}, Bart and Gatz, {Susanne A.} and Michela Casanova and Hjalgrim, {Lisa Lyngsie} and Charlotte Firth and Keith Wheatley and Pamela Kearns and Wenyu Liu and Amanda Kirkham and Helen Rees and Gianni Bisogno and Ajla Wasti and Sara Wakeling and Delphine Heenen and Tweddle, {Deborah A.} and Merks, {Johannes H.M.} and Meriel Jenney",

note = "Publisher Copyright: {\textcopyright} 2024 by the authors.",

year = "2024",

month = oct,

doi = "10.3390/cancers16193427",

language = "English",

volume = "16",

journal = "Cancers",

issn = "2072-6694",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "19",

}

Chisholm, J, Mandeville, H, Adams, M, Minard-Collin, V, Rogers, T, Kelsey, A, Shipley, J, van Rijn, RR, de Vries, I, van Ewijk, R, de Keizer, B, Gatz, SA, Casanova, M, Hjalgrim, LL, Firth, C, Wheatley, K, Kearns, P, Liu, W, Kirkham, A, Rees, H, Bisogno, G, Wasti, A, Wakeling, S, Heenen, D, Tweddle, DA, Merks, JHM & Jenney, M 2024, 'Correction to: Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) (Cancers, (2024), 16, 5, (998), 10.3390/cancers16050998)', Cancers, vol. 16, no. 19, 3427. https://doi.org/10.3390/cancers16193427

Correction to: Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) (Cancers, (2024), 16, 5, (998), 10.3390/cancers16050998). / Chisholm, Julia; Mandeville, Henry; Adams, Madeleine et al.
In: Cancers, Vol. 16, No. 19, 3427, 10.2024.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Correction to

T2 - Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) (Cancers, (2024), 16, 5, (998), 10.3390/cancers16050998)

AU - Chisholm, Julia

AU - Mandeville, Henry

AU - Adams, Madeleine

AU - Minard-Collin, Veronique

AU - Rogers, Timothy

AU - Kelsey, Anna

AU - Shipley, Janet

AU - van Rijn, Rick R.

AU - de Vries, Isabelle

AU - van Ewijk, Roelof

AU - de Keizer, Bart

AU - Gatz, Susanne A.

AU - Casanova, Michela

AU - Hjalgrim, Lisa Lyngsie

AU - Firth, Charlotte

AU - Wheatley, Keith

AU - Kearns, Pamela

AU - Liu, Wenyu

AU - Kirkham, Amanda

AU - Rees, Helen

AU - Bisogno, Gianni

AU - Wasti, Ajla

AU - Wakeling, Sara

AU - Heenen, Delphine

AU - Tweddle, Deborah A.

AU - Merks, Johannes H.M.

AU - Jenney, Meriel

PY - 2024/10

Y1 - 2024/10

N2 - The authors wish to make corrections to the authorship and title of [1]. The corrected authorship is as follows: Julia Chisholm and Henry Mandeville contributed equally to the first authorship. Johannes H. M. Merks and Meriel Jenney contributed equally to senior authorship. In the title FAR-RMS has been corrected to FaR-RMS. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

AB - The authors wish to make corrections to the authorship and title of [1]. The corrected authorship is as follows: Julia Chisholm and Henry Mandeville contributed equally to the first authorship. Johannes H. M. Merks and Meriel Jenney contributed equally to senior authorship. In the title FAR-RMS has been corrected to FaR-RMS. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

UR - http://www.scopus.com/inward/record.url?scp=85206586030&partnerID=8YFLogxK

U2 - 10.3390/cancers16193427

DO - 10.3390/cancers16193427

M3 - Comment/Letter to the editor

AN - SCOPUS:85206586030

SN - 2072-6694

VL - 16

JO - Cancers

JF - Cancers

IS - 19

M1 - 3427

ER -

Correction to: Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) (Cancers, (2024), 16, 5, (998), 10.3390/cancers16050998)

Abstract

Access to Document

Other files and links

Fingerprint

Research output

Frontline and Relapsed Rhabdomyosarcoma (FAR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)

Cite this